Wedge surgery or radiation for high-risk early-stage lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This trial compares two treatments for early-stage lung cancer: a small surgery called wedge resection or a focused type of radiation (SBRT). It is for patients who may be at higher risk for standard surgery due to age or lung/heart health issues.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older
- You must have a confirmed non-small cell lung cancer that has not spread to lymph nodes or other organs
- Your tumor must be in the outer part of the lung and considered treatable by both wedge surgery and radiation
- You need to be able to walk and care for yourself (ECOG score of 0-2)
- You must meet at least one high-risk criteria (e.g., poor lung function on breathing tests) or two secondary criteria (e.g., age 80 or older, reduced heart function)
- You must not have other lung diseases like interstitial lung disease or have had prior radiation to the chest that would limit this treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a newer, more precise way of giving radiation for lung cancer tumors that are near the center of the chest. The goal is to see if using a smaller treatment area can reduce side effects while still killing the cancer.
This trial tests adding targeted radiation before standard immunotherapy and chemotherapy for people with stage 2-3 non-small cell lung cancer that can be surgically removed. The goal is to see if the radiation helps shrink the tumor more before surgery.
This trial compares two treatments for early-stage lung cancer: a new method using a thin tube (bronchoscope) to guide microwaves that "cook" the tumor, versus a very focused type of radiation (SBRT). The goal is to see which one is safer and works better for people who cannot have surgery or choose not to.
This trial compares two ways to treat early-stage lung cancer: surgery or a precise type of radiation called stereotactic radiotherapy. It aims to find out which approach works best for people whose cancer is small and has not spread.
This trial studies a precise, high-dose radiation technique (SBRT) to treat tumors in the lungs. It may help control cancer in people who either have early-stage lung cancer that is not fully operable or have limited lung metastases from other cancers.
This study compares two treatments—removing only part of the lung (sublobar resection) versus a focused radiation approach (stereotactic ablative radiotherapy)—for early-stage non-small cell lung cancer. It aims to see which option works better with fewer problems for the right patients.
Hear when a new Lung Cancer (NSCLC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.